Login / Signup
HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance.
Devis Pascut
Muhammad Yogi Pratama
Claudio Tiribelli
Published in:
Hepatic oncology (2020)
Keyphrases
</>
public health
risk assessment
replacement therapy